Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    ExpandedMedlinePlus Genetics topic: Melanoma added; no deletions.
    Difference
    0.1%
    Check dated 2025-10-20T12:57:13.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    - Removed the MedlinePlus Genetics topic about Melanoma, reducing the genetics-related content on the page.
    Difference
    0.1%
    Check dated 2025-10-13T07:27:20.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:56:01.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic on Melanoma and updated the page revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-29T02:55:00.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2. The older Revision: v3.0.1 tag and the Back to Top element have been removed, and the MedlinePlus Genetics topic 'Melanoma' has been deleted.
    Difference
    0.2%
    Check dated 2025-09-14T18:52:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Melanoma under MedlinePlus Genetics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T13:53:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.